Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286510399> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4286510399 endingPage "979" @default.
- W4286510399 startingPage "975" @default.
- W4286510399 abstract "To date limited information about cefiderocol use is provided by real life studies. Our aim is to evaluate characteristics and outcome of patients with Gram-negative infections with limited therapeutic options treated with cefiderocol in combination or monotherapy. We retrospectively collected data on demographical, clinical characteristics and clinical cure, in-hospital and 30-days mortality, microbiological failure and Clostridioides difficile infections of all patients ≥ 18 years old treated with cefiderocol for ≥ 48 h. There were 18 patients of which 14 (77.8%) treated with cefiderocol in combination and 4 (22.2%) with monotherapy. Median age was 54.5 (IQR 35.25–65.75) vs 70.5 (IQR 57.5–78.25) years old, respectively and ward of admission was the ICU in the 78.57% vs 100% of cases. In the 50% vs 100% of cases infections were VAP with concomitant bloodstream infections. Median SOFA score was 10 (IQR 4.5–12.5) vs 5 (IQR 4–6) and APACHE II score was 13.5 (IQR 7.5–18) vs 16 (IQR 8.5–23.5), respectively. Isolated pathogen was carbapenems-resistant Acinetobacter baumannii in 78.57% vs 100% of cases. Median duration of cefiderocol treatment was 9.5 (IQR 7–13.25) vs 9 days (IQR 5.5–12.5) and in 77.8% patients it was used in combination therapy, of which 57.1% were colistin-spairing regimens. Clinical cure was achieved in 64.29% for combination therapy vs 75% of monotherapy treated patients, 30-days mortality rate was 28.57% vs 25% and 30-day ICU admission rate was 14.29% vs 50%, respectively. No statistically significant differences were observed between combination therapy and monotherapy treated patients. To date, no differences have been demonstrated between cefiderocol monotherapy or combination. Further studies are required to understand whether cefiderocol combination therapy could provide an advantage in outcome in seriously-ill patients." @default.
- W4286510399 created "2022-07-22" @default.
- W4286510399 creator A5002143975 @default.
- W4286510399 creator A5021647339 @default.
- W4286510399 creator A5031309957 @default.
- W4286510399 creator A5034940912 @default.
- W4286510399 creator A5035303214 @default.
- W4286510399 creator A5036097214 @default.
- W4286510399 creator A5044933996 @default.
- W4286510399 creator A5056339324 @default.
- W4286510399 date "2022-09-01" @default.
- W4286510399 modified "2023-10-14" @default.
- W4286510399 title "Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key?" @default.
- W4286510399 cites W2211192799 @default.
- W4286510399 cites W2599881574 @default.
- W4286510399 cites W2736356388 @default.
- W4286510399 cites W2753440878 @default.
- W4286510399 cites W3087097003 @default.
- W4286510399 cites W3092173712 @default.
- W4286510399 cites W3092383626 @default.
- W4286510399 cites W3127762568 @default.
- W4286510399 cites W3167620810 @default.
- W4286510399 cites W3217749790 @default.
- W4286510399 cites W4220764592 @default.
- W4286510399 doi "https://doi.org/10.1016/j.jiph.2022.07.006" @default.
- W4286510399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35961239" @default.
- W4286510399 hasPublicationYear "2022" @default.
- W4286510399 type Work @default.
- W4286510399 citedByCount "7" @default.
- W4286510399 countsByYear W42865103992022 @default.
- W4286510399 countsByYear W42865103992023 @default.
- W4286510399 crossrefType "journal-article" @default.
- W4286510399 hasAuthorship W4286510399A5002143975 @default.
- W4286510399 hasAuthorship W4286510399A5021647339 @default.
- W4286510399 hasAuthorship W4286510399A5031309957 @default.
- W4286510399 hasAuthorship W4286510399A5034940912 @default.
- W4286510399 hasAuthorship W4286510399A5035303214 @default.
- W4286510399 hasAuthorship W4286510399A5036097214 @default.
- W4286510399 hasAuthorship W4286510399A5044933996 @default.
- W4286510399 hasAuthorship W4286510399A5056339324 @default.
- W4286510399 hasBestOaLocation W42865103991 @default.
- W4286510399 hasConcept C126322002 @default.
- W4286510399 hasConcept C2776315533 @default.
- W4286510399 hasConcept C2776999253 @default.
- W4286510399 hasConcept C2777465075 @default.
- W4286510399 hasConcept C2777637488 @default.
- W4286510399 hasConcept C2778384902 @default.
- W4286510399 hasConcept C2779259085 @default.
- W4286510399 hasConcept C2779384505 @default.
- W4286510399 hasConcept C501593827 @default.
- W4286510399 hasConcept C523546767 @default.
- W4286510399 hasConcept C54355233 @default.
- W4286510399 hasConcept C71924100 @default.
- W4286510399 hasConcept C86803240 @default.
- W4286510399 hasConcept C89423630 @default.
- W4286510399 hasConceptScore W4286510399C126322002 @default.
- W4286510399 hasConceptScore W4286510399C2776315533 @default.
- W4286510399 hasConceptScore W4286510399C2776999253 @default.
- W4286510399 hasConceptScore W4286510399C2777465075 @default.
- W4286510399 hasConceptScore W4286510399C2777637488 @default.
- W4286510399 hasConceptScore W4286510399C2778384902 @default.
- W4286510399 hasConceptScore W4286510399C2779259085 @default.
- W4286510399 hasConceptScore W4286510399C2779384505 @default.
- W4286510399 hasConceptScore W4286510399C501593827 @default.
- W4286510399 hasConceptScore W4286510399C523546767 @default.
- W4286510399 hasConceptScore W4286510399C54355233 @default.
- W4286510399 hasConceptScore W4286510399C71924100 @default.
- W4286510399 hasConceptScore W4286510399C86803240 @default.
- W4286510399 hasConceptScore W4286510399C89423630 @default.
- W4286510399 hasIssue "9" @default.
- W4286510399 hasLocation W42865103991 @default.
- W4286510399 hasLocation W42865103992 @default.
- W4286510399 hasLocation W42865103993 @default.
- W4286510399 hasOpenAccess W4286510399 @default.
- W4286510399 hasPrimaryLocation W42865103991 @default.
- W4286510399 hasRelatedWork W2031679173 @default.
- W4286510399 hasRelatedWork W2058835846 @default.
- W4286510399 hasRelatedWork W2117992352 @default.
- W4286510399 hasRelatedWork W2123498714 @default.
- W4286510399 hasRelatedWork W2494996584 @default.
- W4286510399 hasRelatedWork W2738070685 @default.
- W4286510399 hasRelatedWork W2794347472 @default.
- W4286510399 hasRelatedWork W2993419244 @default.
- W4286510399 hasRelatedWork W3103878392 @default.
- W4286510399 hasRelatedWork W4310214318 @default.
- W4286510399 hasVolume "15" @default.
- W4286510399 isParatext "false" @default.
- W4286510399 isRetracted "false" @default.
- W4286510399 workType "article" @default.